These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tocainide for arrhythmias. Med Lett Drugs Ther; 1985 Feb; 27(680):9-11. PubMed ID: 3918240 [No Abstract] [Full Text] [Related]
4. Tocainide--an alternative to mexiletine. Drug Ther Bull; 1982 Jul; 20(14):55-6. PubMed ID: 6814882 [No Abstract] [Full Text] [Related]
5. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias. Schwartzkopff B; Schilling G; Simon H Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021 [TBL] [Abstract][Full Text] [Related]
6. [Electrophysiologic and clinical study of tocainide, a new class IB drug]. Vergara G; Disertori M; Bettini R; Stirpe E; Gramegna L; Furlanello F Minerva Cardioangiol; 1986 Nov; 34(11):711-9. PubMed ID: 3101001 [No Abstract] [Full Text] [Related]
9. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645 [TBL] [Abstract][Full Text] [Related]
10. Mexiletine and tocainide: a profile of two lidocaine analogs. Woosley RL Ration Drug Ther; 1987 Mar; 21(3):1-7. PubMed ID: 3116601 [No Abstract] [Full Text] [Related]
11. Tocainide: a new drug for ventricular arrhythmias. Volosin KJ; Greenspon AJ Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938 [No Abstract] [Full Text] [Related]
12. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats. McLaran CJ; Hossack KF; Neilson GH; Siskind V J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321 [TBL] [Abstract][Full Text] [Related]
14. Mexiletine and tocainide: orally active congeners of lidocaine. Wulf BG Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416 [No Abstract] [Full Text] [Related]
15. Chemistry, pharmacology, antiarrhythmic efficacy and adverse effects of tocainide hydrochloride, an orally active structural analog of lidocaine. Alpert JS; Haffajee CI; Young MD Pharmacotherapy; 1983; 3(6):316-23. PubMed ID: 6419205 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias]. Gebhardt A; Schmuderer R; Hilpert P Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425 [TBL] [Abstract][Full Text] [Related]
17. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent. Morganroth J; Nestico PF; Horowitz LN Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446 [TBL] [Abstract][Full Text] [Related]
18. [Clinical pharmacology of anti-arrhythymia agents. II. Lignocaine, mexiletine, tocainide, phenytoin]. Witkowska M Kardiol Pol; 1981; 24(11-12):803-13. PubMed ID: 6804681 [No Abstract] [Full Text] [Related]
19. [Use of lidocaine in the treatment of ventricular arrhythmias]. Antonini FM; Fumagalli C; Bertini G; Ricci F Cardiol Prat; 1970 Jun; 21(3):141-54. PubMed ID: 5511551 [No Abstract] [Full Text] [Related]
20. Tocainide: a new oral antiarrhythmic agent. Kutalek SP; Morganroth J; Horowitz LN Ann Intern Med; 1985 Sep; 103(3):387-91. PubMed ID: 3927807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]